Three Keys To Mitigating Risk In Adaptive Trials

January 5, 2019

Adaptive trial designs can can accelerate timelines and reduce costs while simultaneously improving
program success rates. In this article, Sy Pretorius, Parexel's Senior Vice President and Chief Scientific Officer, offers insights about important steps to conduct successful adaptive trials.

Previous Article
Improving Drug Development & Patient Access With the Right People, Processes, and Culture
Improving Drug Development & Patient Access With the Right People, Processes, and Culture

Next Flipbook
Drug development innovations that work: Adaptive trial design - BioPharma Dive
Drug development innovations that work: Adaptive trial design - BioPharma Dive

×

Lets start a conversation...

First Name
Last Name
Job Title
Company Name
Country
Therapeutic Area Interest - optional
Tell us how we can help
Thank you! We'll be in touch soon.
Error - something went wrong!